We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$226B
AUM Growth
+$4.98B
Cap. Flow
-$1.09B
Cap. Flow %
-0.48%
Top 10 Hldgs %
14.11%
Holding
3,794
New
174
Increased
1,922
Reduced
1,417
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 17.16%
2 Financials 13.52%
3 Healthcare 11.13%
4 Consumer Discretionary 9.37%
5 Industrials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMBC
3501
DELISTED
Pacific Mercantile Bancorp
PMBC
$101K ﹤0.01%
+10,400
New +$101K
HLTH
3502
DELISTED
Nobilis Health Corp.
HLTH
$99K ﹤0.01%
+82,479
New +$114K
DMF
3503
DELISTED
BNY Mellon Municipal Income
DMF
$98K ﹤0.01%
11,985
BLCM
3504
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$96K ﹤0.01%
+1,306
New +$102K
BBW icon
3505
Build-A-Bear
BBW
$425M
$93K ﹤0.01%
+12,110
New +$106K
LEO
3506
BNY Mellon Strategic Municipals
LEO
$383M
$93K ﹤0.01%
12,078
-4,841
-29% -$37K
TI
3507
DELISTED
Telecom Italia
TI
$88K ﹤0.01%
11,872
-14,163
-54% -$129K
ANH
3508
DELISTED
Anworth Mortgage Asset Corporation
ANH
$87K ﹤0.01%
17,334
-207,932
-92% -$1.02M
MIN
3509
Aberdeen Intermediate Income Fund
MIN
$274M
$86K ﹤0.01%
+22,327
New +$86.5K
AKRX
3510
CALL
DELISTED
Akorn Inc
AKRX
$86K ﹤0.01%
+5,200
New +$79.8K
INO icon
3511
Inovio Pharmaceuticals
INO
$55.7M
$84K ﹤0.01%
+1,779
New +$98.1K
TTPH
3512
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$84K ﹤0.01%
1,175
+50
+4% +$3.53K
JYNT icon
3513
The Joint Corp
JYNT
$118M
$82K ﹤0.01%
10,000
VATE icon
3514
INNOVATE Corp
VATE
$111M
$80K ﹤0.01%
1,365
ASXC
3515
DELISTED
Asensus Surgical, Inc.
ASXC
$80K ﹤0.01%
1,479
-65
-4% -$2.37K
LCTX icon
3516
Lineage Cell Therapeutics
LCTX
$269M
$78K ﹤0.01%
42,973
-30,939
-42% -$62.3K
UMC icon
3517
United Microelectronic
UMC
$47.7B
$77K ﹤0.01%
27,225
-425
-2% -$1.16K
CALA
3518
DELISTED
Calithera Biosciences, Inc
CALA
$76K ﹤0.01%
+762
New +$86.3K
CFMS
3519
DELISTED
Conformis, Inc. Common Stock
CFMS
$73K ﹤0.01%
2,323
-41
-2% -$1.42K
PNNT
3520
Pennant Park Investment Corp
PNNT
$215M
$72K ﹤0.01%
+10,289
New +$72.3K
XXII
3521
22nd Century Group
XXII
$1.38M
0
TA
3522
DELISTED
TravelCenters of America LLC
TA
$72K ﹤0.01%
4,139
-6
-0.1% -$104
PETX
3523
DELISTED
Aratana Therapeutics, Inc.
PETX
$70K ﹤0.01%
+16,460
New +$83K
JASO
3524
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$70K ﹤0.01%
+10,237
New +$72K
DX
3525
Dynex Capital
DX
$3.15B
$69K ﹤0.01%
+3,546
New +$69.1K

Similar funds

Ameriprise's Q2 2018 Portfolio in Review

As of Q2 2018, Ameriprise held 3,794 positions worth $226B, up 2.3% from $221B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Ameriprise's Q2 2018 filing shows 174 new, 1,922 increased, 1,417 reduced and 161 closed positions. Its largest new stake was GreenSky, Inc. Class A Common Stock: 3,371,225 shares worth $71.3M. The largest sale was iShares MSCI EAFE Value ETF, an estimated $879M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Ameriprise's largest Q2 2018 buy was GreenSky, Inc. Class A Common Stock: 3,371,225 shares worth $71.3M.
  • Ameriprise added most to Bristol-Myers Squibb in Q2 2018, an estimated $448M increase.
  • Ameriprise's biggest Q2 2018 reduction was iShares MSCI EAFE Value ETF, cutting an estimated $879M.
  • Ameriprise fully exited Time Warner Inc in Q2 2018, selling an estimated $231M.
  • Ameriprise's ten largest holdings make up 14% of its $226B portfolio in Q2 2018.
  • Ameriprise opened 174 new positions and closed 161 in Q2 2018.
  • Ameriprise's portfolio value rose 2.3% quarter-over-quarter to $226B.

Based on Ameriprise's 13F filing for Q2 2018, filed 14 Aug 2018.